Financhill
Back

Arcutis Biotherapeutics, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
68

ARQT
Arcutis Biotherapeutics, Inc.

Last Price:
$29.44
Seasonality Move:
61.76%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARQT is experiencing selling pressure, which indicates risk of future bearish movement.

Arcutis Biotherapeutics, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 28.73 Buy
20-day SMA: 29.72 Sell
50-day SMA: 26.21 Buy
200-day SMA: 18.07 Buy
8-day EMA: 29.01 Buy
20-day EMA: 28.81 Buy
50-day EMA: 26.41 Buy
200-day EMA: 19.51 Buy

Arcutis Biotherapeutics, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.64 Buy
Relative Strength Index (14 RSI): 56.04 Buy
Chaikin Money Flow: -1318700 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.28 - 30.68) Sell
Bollinger Bands (100): (16.26 - 27.08) Buy

Arcutis Biotherapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Arcutis Biotherapeutics, Inc. Stock

Is Arcutis Biotherapeutics, Inc. Stock a Buy?

ARQT Technical Analysis vs Fundamental Analysis

Buy
68
Arcutis Biotherapeutics, Inc. (ARQT) is a Buy

Is Arcutis Biotherapeutics, Inc. a Buy or a Sell?

Arcutis Biotherapeutics, Inc. Stock Info

Market Cap:
3.6B
Price in USD:
29.31
Share Volume:
1.4M

Arcutis Biotherapeutics, Inc. 52-Week Range

52-Week High:
31.77
52-Week Low:
11.13
Buy
68
Arcutis Biotherapeutics, Inc. (ARQT) is a Buy

Arcutis Biotherapeutics, Inc. Share Price Forecast

Is Arcutis Biotherapeutics, Inc. Stock a Buy?

Fundamental Analysis of Arcutis Biotherapeutics, Inc.

Is Arcutis Biotherapeutics, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.19 per share, and an increase next year of $0.60 per share.

Technical Analysis of Arcutis Biotherapeutics, Inc.

Should I short Arcutis Biotherapeutics, Inc. stock?

* Arcutis Biotherapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.